fluoxetine and phentermine

fluoxetine has been researched along with phentermine in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (24.00)18.2507
2000's14 (56.00)29.6817
2010's5 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Glen, RC; Lowe, R; Mitchell, JB1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bostwick, JM; Brown, TM1
Njo, L; Rich, JM; Roberts, KW; Smith, KP1
Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS1
Archer, SL; Nelson, DP; Reeve, HL; Weir, EK1
Cowley, G; Springen, K1
Marshall, M; Roth, JD; Rowland, NE1
Carino, JS; Devlin, MJ; Goldfein, JA; Wolk, SL1
Callahan, BT; Ricaurte, GA; Yuan, J1
Lo, J; Robertson, K; Rowland, NE1
Aspley, S; Auerbach, S; Brammer, R; Fray, A; Heal, D; Tao, R1
Jones, SL; Miller, DK; Wellman, PJ1
Dunlop, PC; Johnson, GJ; Leis, LA; Weir, EK1
Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W1
Arterburn, D2
Arterburn, D; DeLaet, D; Flum, D1
Baumann, MH; Rothman, RB; Zolkowska, D1
Atkinson, RL; Dhurandhar, NV; Rahko, PS; Whigham, LD1

Reviews

6 review(s) available for fluoxetine and phentermine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Challenges in obesity management.
    Southern medical journal, 1998, Volume: 91, Issue:8

    Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline

1998
Pharmacological and surgical treatment of obesity.
    Evidence report/technology assessment (Summary), 2004, Issue:103

    Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate

2004
Obesity.
    Clinical evidence, 2003, Issue:10

    Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine

2003
Obesity.
    Clinical evidence, 2004, Issue:11

    Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors

2004
Obesity.
    Clinical evidence, 2005, Issue:13

    Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Gastric Bypass; Gastroplasty; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine

2005

Trials

1 trial(s) available for fluoxetine and phentermine

ArticleYear
Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.
    The International journal of eating disorders, 2000, Volume: 28, Issue:3

    Topics: Adult; Appetite Depressants; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Hyperphagia; Middle Aged; Obesity; Phentermine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2000

Other Studies

18 other study(ies) available for fluoxetine and phentermine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Fluoxetine (Prozac) and other drugs for treatment of obesity.
    The Medical letter on drugs and therapeutics, 1994, Nov-25, Volume: 36, Issue:936

    Topics: Clinical Trials as Topic; Drug Therapy, Combination; Fenfluramine; Fluoxetine; Humans; Obesity; Phentermine

1994
A toxic reaction from combining fluoxetine and phentermine.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Appetite Depressants; Arousal; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Phentermine

1996
Unusual hypotension and bradycardia in a patient receiving fenfluramine, phentermine, and fluoxetine.
    Anesthesiology, 1998, Volume: 88, Issue:2

    Topics: Anesthesia, Conduction; Anesthetics, Intravenous; Appetite Depressants; Bradycardia; Drug Interactions; Fenfluramine; Fentanyl; Fluoxetine; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Phentermine; Selective Serotonin Reuptake Inhibitors; Sympathomimetics

1998
Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology.
    The American journal of physiology, 1999, Volume: 276, Issue:2

    Topics: Animals; Blood Pressure; Cyclohexanols; Electric Conductivity; Electrophysiology; Fluoxetine; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Phentermine; Potassium Channel Blockers; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1999
After fen-phen.
    Newsweek, 1997, Sep-29, Volume: 130, Issue:13

    Topics: Antidepressive Agents, Second-Generation; Appetite Depressants; Consumer Product Safety; Fenfluramine; Fluoxetine; Heart Valve Diseases; Humans; Obesity; Phentermine; Risk Factors; United States; Weight Loss

1997
Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.
    Psychopharmacology, 2000, Volume: 149, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Desipramine; Dexfenfluramine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Female; Fluoxetine; Norepinephrine; Phentermine; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Receptor Agonists; Time Factors

2000
Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Synapse (New York, N.Y.), 2000, Dec-15, Volume: 38, Issue:4

    Topics: Animals; Anorexia; Appetite Depressants; Biogenic Monoamines; Body Temperature; Body Weight; Brain; Dopamine Antagonists; Eating; Fluoxetine; Liver; Male; Mice; Oxidoreductases; Phentermine; Time Factors

2000
Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol.
    Psychopharmacology, 2001, Volume: 157, Issue:2

    Topics: Animals; Appetite Depressants; Dexfenfluramine; Drug Combinations; Eating; Female; Fluoxetine; Food Deprivation; Mice; Mice, Inbred C57BL; Phentermine; Serotonin Receptor Agonists

2001
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
    European journal of pharmacology, 2002, Jun-07, Volume: 445, Issue:1-2

    Topics: Aminorex; Animals; Drug Combinations; Fenfluramine; Fluoxetine; Hypothalamus; Male; Phentermine; Rats; Rats, Sprague-Dawley; Serotonin

2002
Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:1

    Topics: Animals; Antidepressive Agents, Second-Generation; Appetite Depressants; Body Weight; Cyclobutanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Eating; Fenfluramine; Fluoxetine; Male; Norepinephrine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors

2003
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:12

    Topics: Appetite Depressants; Blood Platelets; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Humans; Hydrogen-Ion Concentration; Norfenfluramine; Phentermine; Reserpine; Secretory Vesicles; Selective Serotonin Reuptake Inhibitors; Serotonin

2003
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:2

    Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrochemistry; Fluoxetine; Heart Diseases; Hydroxyindoleacetic Acid; Indicators and Reagents; Lung Diseases; Male; Methamphetamine; Microdialysis; Mitogens; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical

2006
Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    International journal of obesity (2005), 2007, Volume: 31, Issue:5

    Topics: Adult; Appetite Depressants; Body Mass Index; Drug Therapy, Combination; Fenfluramine; Fluoxetine; Heart Valve Diseases; Humans; Medical Records; Obesity; Phentermine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Ultrasonography; Weight Loss

2007